Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
Ab170844-100μg | 100μg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $69.90 | |
Ab170844-1mg | 1mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $327.90 | |
Ab170844-5mg | 5mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $687.90 | |
Ab170844-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,107.90 |
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
Product Name | Cusatuzumab (anti-CD70) - Primary antibody, specific to CD70, >95%, high purity, Human IgG1 |
---|---|
Synonyms | CD 27L antibody; CD 70 antibody; CD27 L antibody; CD27 LG antibody; CD27 ligand antibody; CD27-L antibody; CD27L antibody; CD27LG antibody; CD70 antibody; CD70 antigen antibody; CD70 molecule antibody; CD70_HUMAN antibody; Ki 24 antigen antibody; Ki24 ant |
Specifications & Purity | ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot |
Specificity | CD70 |
Conjugation | Unconjugated |
Grade | Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
Action Type | INHIBITOR |
Mechanism of action | INHIBITOR of CD70 antigen inhibitor |
Product Description | Cusatuzumab (anti-CD70) is a human αCD70 monoclonal antibody. Cusatuzumab (anti-CD70) shows cytotoxicity activity with enhanced antibody-dependent cellular. Cusatuzumab (anti-CD70) reduces leukemia stem cells (LSCs) and triggers gene signatures related to myeloid differentiation and apoptosis. Cusatuzumab (anti-CD70) has the potential for the research of Acute myeloid leukemia (AML). |
Isotype | Human IgG1 |
---|---|
Light Chain Type | lambda C2 |
SDS-PAGE | 27.5 kDa (Light Chain) & 51.0 kDa (Heavy Chain), under reducing conditions; 170.7 kDa, under non-reducing conditions. |
Purification Method | Protein A purified |
Purity | >95% |
Form | Liquid |
Concentration | Lot by Lot |
Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
Shipped In | Ice chest + Ice pads |
Stability And Storage | Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle. |
CAS | 1864871-20-4 |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
ZJ24F0607381 | Certificate of Analysis | Jun 26, 2024 | Ab170844 |
ZJ23F1001417 | Certificate of Analysis | Oct 26, 2023 | Ab170844 |
ZJ23F1001418 | Certificate of Analysis | Oct 26, 2023 | Ab170844 |
1. Bowman, M R MR and 5 more authors.. (1994) The cloning of CD70 and its identification as the ligand for CD27.. Journal of immunology (Baltimore, Md. : 1950), (15): [PMID:8120384] |
2. Goodwin, R G RG and 9 more authors.. (1993) Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor.. Cell, (7): [PMID:8387892] |
3. Izawa, Kazushi K and 15 more authors.. (2017) Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection.. The Journal of experimental medicine, [PMID:28011863] |
4. Abolhassani, Hassan H and 32 more authors.. (2017) Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency.. The Journal of experimental medicine, [PMID:28011864] |